0000899243-22-002207.txt : 20220118
0000899243-22-002207.hdr.sgml : 20220118
20220118183406
ACCESSION NUMBER: 0000899243-22-002207
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220106
FILED AS OF DATE: 20220118
DATE AS OF CHANGE: 20220118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Isaacs Randi
CENTRAL INDEX KEY: 0001857797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40366
FILM NUMBER: 22536253
MAIL ADDRESS:
STREET 1: 1030 MASSACHUSETTS AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc.
CENTRAL INDEX KEY: 0001785530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823523180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1030 MASSACHUSETTS AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: 617-952-0555
MAIL ADDRESS:
STREET 1: 1030 MASSACHUSETTS AVENUE
STREET 2: SUITE 210
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-06
0
0001785530
Werewolf Therapeutics, Inc.
HOWL
0001857797
Isaacs Randi
C/O WEREWOLF THERAPEUTICS, INC.
1030 MASSACHUSETTS AVENUE, SUITE 210
CAMBRIDGE
MA
02138
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
11.55
2022-01-06
4
A
0
79516
0.00
A
2032-01-05
Common Stock
79516
79516
D
The option was granted on January 6, 2022 with a Vesting Commencement Date of January 1, 2022. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through January 1, 2026.
/s/ Reid Leonard, Attorney-in-fact
2022-01-18